Who owns NLS PHARMACEUTICS LTD?
- Ticker: NLSP
- CUSIP Number: h57830103
Tip: Access positions for across all investors
Analyze quarterly positions in Nls Pharmaceutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nls Pharmaceutics stock
Who bought or sold NLS PHARMACEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 5.7M | $1.0M | 0% | Mar 2024 |
|
| Armistice Capital | 2.2M | $391k | 100% | Mar 2024 |
|
| XTX Topco | 26k | $4.7k | 100% | Mar 2024 |
|
| Citadel Advisors | 19k | $3.5k | 100% | Mar 2024 |
|
| Geode Capital Management | 14k | $2.6k | 0% | Mar 2024 |
|
| Bank of America Corporation | 90.00 | $16.002000 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Nls Pharmaceutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Wells Fargo & Company | Dec 2023 | 57k | $33k |